1. ScholarBank@NUS

Wei Peng Yong

rp05452

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wei Peng Yong
Variants
Yong, W.-P.
Yong, W.P.
Peng, Y.W.
 
Main Affiliation
 
Faculty
 
Email
csiywp@nus.edu.sg
 

Publications

Refined By:
Subject:  Life Sciences & Biomedicine
Policy:  Open

Results 1-7 of 7 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)
11-Mar-2022A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignanciesHo, Jingshan ; Heong, Valerie; Yong, Wei Peng ; Soo, Ross ; Chee, Cheng Ean ; Wong, Andrea ; Sundar, Raghav; Thian, Yee Liang ; Gopinathan, Anil ; Pang, Mei Yan; Koe, Priscillia; Jeraj, Santhiay Nathan; Soe, Phyu Pyar; Soe, Mu Yar; Tang, Tiffany ; Ng, Matthew CH; Tai, David WM ; Tan, Tira JY ; Xu, Hongmei; Chang, Hua; Landesman, Yosef; Shah, Jatin ; Shacham, Sharon; Lee, Soo Chin ; Tan, Daniel SW ; Goh, Boon Cher ; Tan, David SP 
215-Apr-2023A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological MalignanciesChee, Cheng E ; Ooi, Melissa ; Lee, Soo-Chin ; Sundar, Raghav ; Heong, Valerie; Yong, Wei-Peng ; Ng, Chin Hin ; Wong, Andrea; Lim, Joline SJ ; Tan, David SP ; Soo, Ross ; Tan, Joshua TC; Yang, Song; Thura, Min; Al-Aidaroos, Abdul Qader; Chng, Wee Joo ; Zeng, Qi ; Goh, Boon-Cher 
316-Feb-2023Clinical outcome and prognostic factors for Asian patients in Phase I clinical trialsLoh, Jerold; Wu, Jiaxuan; Chieng, Jenny; Chan, Aurora; Yong, Wei-Peng ; Sundar, Raghav ; Lee, Soo-Chin ; Wong, Andrea; Lim, Joline SJ ; Tan, David SP ; Soo, Ross ; Goh, Boon-Cher ; Tai, Bee-Choo ; Chee, Cheng E 
43-May-2016Gelsolin-mediated activation of PI3K/Akt pathway is crucial for hepatocyte growth factor-induced cell scattering in gastric carcinomaHuang, Baohua ; DENG SHUO ; LOO SER YUE ; ARPITA DATTA ; YAP YAN LIN ; Yan, Benedict; OOI CHIA HUEY ; DINH THUY DUONG ; ZHUO JINGLI ; LALCHHANDAMI TOCHHAWNG ; SUMA GOPINADHAN ; Jegadeesan, Tamilarasi; TAN BOON OOI,PATRICK ; SALTO-TELLEZ,MANUEL ; YONG WEI PENG ; SOONG CHUAN TECK,RICHIE ; YEOH KHAY GUAN ; GOH YAW CHONG ; PETER EDWARD LOBIE ; YANG HE ; ALAN PREM KUMAR ; Maciver, Sutherland K; SO BOK YAN,JIMMY ; Yap Suen Mei,Celestial Therese 
51-Jul-2016High efficacy of BAY 1187982, an FGFR2-ADC, in overcoming drug resistance in a diffuse type gastric cancer patient-derived xenograft model with acquired resistance to pan-FGFR inhibitor AZD4547Lau, Wen Min ; Teng, Eileen ; Huang, Kie Kyon ; Tan, Jin Wei ; Teh, Ming ; Yong, Wei Peng ; Sommer, Anette; Schatz, Christoph A; Tan, Patrick ; Chan, Shing Leng ; So, Jimmy 
623-Feb-2022Phase Ib Dose-Finding Study of Varlitinib Combined with Weekly Paclitaxel With or Without Carboplatin +/- Trastuzumab in Advanced Solid TumorsLee, Matilda Xinwei; Wong, Andrea LA ; Ow, Samuel; Sundar, Raghav ; Tan, David SP ; Soo, Ross A ; Chee, Cheng Ean ; Lim, Joline SJ ; Yong, Wei Peng ; Lim, Siew Eng; Goh, Boon Cher ; Wang, Lingzhi ; Lee, Soo Chin 
71-May-2018Resisting resistance to cancer immunotherapyRAGHAV SUNDAR; Lam, W.S.-T.; Wang, L.Z.; Roudi, R.; Yong, W.-P. ; Syn, N.L.